Srx Health Solutions Inc (SRXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 8,470 | 11,926 | -12,850 | N/A |
| Depreciation Amortization | N/A | 3,931 | 2,601 | 411 | N/A |
| Accounts receivable | N/A | -2,893 | -558 | -2,044 | N/A |
| Accounts payable and accrued liabilities | N/A | -8 | 328 | N/A | N/A |
| Other Working Capital | N/A | -950 | 601 | 424 | N/A |
| Other Operating Activity | 0 | -16,870 | -19,560 | 11,734 | 0 |
| Operating Cash Flow | $N/A | $-8,320 | $-4,662 | $-2,325 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -124 | -54 | N/A | N/A |
| Investing Cash Flow | $N/A | $-124 | $-54 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 5,535 | 5,155 | 5,155 | N/A |
| Debt Issued | N/A | 6,000 | 6,000 | 6,000 | N/A |
| Debt Repayment | N/A | -8,379 | -8,229 | -8,080 | N/A |
| Common Stock Issued | N/A | 41,857 | 3,993 | 4,012 | N/A |
| Common Stock Repurchased | N/A | -1,274 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -6,023 | -3,645 | -4,390 | 0 |
| Financing Cash Flow | $N/A | $37,716 | $3,274 | $2,697 | $N/A |
| Beginning Cash Position | N/A | 3,989 | 3,989 | 3,989 | N/A |
| End Cash Position | N/A | 33,261 | 2,547 | 4,361 | N/A |
| Net Cash Flow | $N/A | $29,272 | $-1,442 | $372 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -8,320 | -4,662 | -2,325 | N/A |
| Capital Expenditure | N/A | -124 | -54 | N/A | N/A |
| Free Cash Flow | 0 | -8,444 | -4,716 | -2,325 | 0 |